Indeed, hypoxia has been found to impair the antitumor immune response by several mechanisms (181–184), such as alteration of NK and T cell activation and effector functions, induction of PD-L1 expression on MDSCs via HIF-1α transcription factor, and attraction of TAMs or Tregs to the tumor bed. This evidence concerns the gene CD274 and neoplasm.